Sign In
Buy AUPH
$15.67
+0.280 (+1.82%)
At Close: Jun 03, 2026
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Aurinia Pharmaceuticals
Cantor Fitzgerald Keeps a Buy Rating on Stemline Therapeutics (STML)
08:28am, Sunday, 29'th Mar 2020
In a report issued on March 27,
Alethia Young
from Cantor Fitzgerald reiterated a
Buy
rating on Stemline Therapeutics (
STML
–
Research Report
), with a price target of
$10.00
. The company’s shar
Analysts Offer Insights on Healthcare Companies: Biocept (BIOC), Becton Dickinson (BDX) and Aurinia Pharmaceuticals (AUPH)
01:04pm, Friday, 27'th Mar 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Biocept (BIOC), Becton Dickinson (BDX) and Aurinia
Largest Lupus Advocacy Summit Transforms to Digital Event Amid Coronavirus Concerns
02:00pm, Thursday, 19'th Mar 2020
While the event was changed from an in-person format to a digital event due to concerns of the coronavirus (COVID-19), the Foundation and its advocates did not let that deter them from their mission.
7 “Perfect 10” Healthcare Stocks to Buy Now
04:15pm, Wednesday, 18'th Mar 2020
Wall Street pros recommend making an investment decision based on multiple factors rather than just a single metric like fundamentals.
Aurinia Pharmaceuticals Establishes U.S. Commercial Operations Center In Rockville, Maryland
10:05am, Tuesday, 17'th Mar 2020Analysts Offer Insights on Healthcare Companies: Entasis Therapeutics Holdings (ETTX) and Zynerba Pharmaceuticals (ZYNE)
11:13am, Thursday, 12'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Entasis Therapeutics Holdings (ETTX) and Zynerba
Analysts Offer Insights on Healthcare Companies: Entasis Therapeutics Holdings (NASDAQ: ETTX) and Zynerba Pharmaceuticals (NASDAQ: ZYNE)
11:13am, Thursday, 12'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Entasis Therapeutics Holdings (
ETTX
–
Research Report
) and Zynerba Pharmaceuticals (
ZYNE
–
Resea
Akebia Therapeutics (AKBA) Received its Third Buy in a Row
11:31am, Wednesday, 11'th Mar 2020
After Mizuho Securities and Piper Sandler gave Akebia Therapeutics (NASDAQ: AKBA) a Buy rating last month, the company received another Buy, this time
Akebia Therapeutics (AKBA) Received its Third Buy in a Row
11:31am, Wednesday, 11'th Mar 2020
After Mizuho Securities and Piper Sandler gave Akebia Therapeutics (NASDAQ:
AKBA
) a Buy rating last month, the company received another Buy, this time from H.C. Wainwright. Analyst
Ed Arce
maintained
Analysts Offer Insights on Healthcare Companies: InspireMD (NSPR) and Paratek Pharmaceuticals (PRTK)
11:31am, Wednesday, 11'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on InspireMD (NSPR) and Paratek Pharmaceuticals (PRTK) with
Analysts Offer Insights on Healthcare Companies: InspireMD (NYSE MKT: NSPR) and Paratek Pharmaceuticals (NASDAQ: PRTK)
11:31am, Wednesday, 11'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on InspireMD (
NSPR
–
Research Report
) and Paratek Pharmaceuticals (
PRTK
–
Research Report
) with bu
